(2-R,4-S,5-R)-3,4-DIMETHYL-2-(ALPHA-(R(FC))-[BIS-(4-TRIFLUOROMETHYLPHENYL)-PHOSPHANYL]-FERROCENYL)-5-PHENYL-[1,3,2]-OXAZAPHOSPHOLIDINE-2-OXIDE
Compound with spectra: 1 NMR
![(2-R,4-S,5-R)-3,4-DIMETHYL-2-(ALPHA-(R(FC))-[BIS-(4-TRIFLUOROMETHYLPHENYL)-PHOSPHANYL]-FERROCENYL)-5-PHENYL-[1,3,2]-OXAZAPHOSPHOLIDINE-2-OXIDE](/api/compound/8CkMnIoDn7h.png?ph=true&h=300&w=458 "(2-R,4-S,5-R)-3,4-DIMETHYL-2-(ALPHA-(R(FC))-[BIS-(4-TRIFLUOROMETHYLPHENYL)-PHOSPHANYL]-FERROCENYL)-5-PHENYL-[1,3,2]-OXAZAPHOSPHOLIDINE-2-OXIDE")
| SpectraBase Compound ID | 8CkMnIoDn7h |
|---|---|
| InChI | InChI=1S/C29H21F6NO2P2.C5H.Fe/c1-19-27(20-7-4-3-5-8-20)38-40(37,36(19)2)26-10-6-9-25(26)39(23-15-11-21(12-16-23)28(30,31)32)24-17-13-22(14-18-24)29(33,34)35;1-2-4-5-3-1;/h3-5,7-8,11-19,27H,1-2H3;1H;/t19-,27-,40?;;/m0../s1 |
| InChIKey | NAQCJVAYFBHTJV-FJVGAGEYSA-N |
| Mol Weight | 708.3 g/mol |
| Molecular Formula | C34H22F6FeNO2P2 |
| Exact Mass | 708.037933 g/mol |
| Enantiomer InChIKey | NAQCJVAYFBHTJV-HPBQBUFCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Methyl 2.beta.-(2'-(m-isopropyl-phenyl)ethyl)-1.beta.,3.alpha.-dimethyl-cyclohexanecarboxylate (so name and structure in Anderson & Botto) but MS (intense fragement at m/z = 187) and RT suggest 2.alpha.-epimer instead, with Reg. No. 19556-80-0? a methyl seco-dehydro-abietate
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
4H-9,12:15,18-Dietheno-28,31-imino-26,23-methenopyrrolo[2,3-n][1,19,6]dioxaazacyclohentriacontine-6,21,24(5H,22H,25H)-trione, 30-ethyl-2-[(3-ethyl-1,5-dihydro-4-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-8,13,14,19-tetrahydro-3,29,34-trimethyl-, (Z,Z,Z)-
Cobalt, bis(cyano-C)(8,11-diethyl-2,3,3a,7,8,9,10,11,12,16,17,20a-dodecahydro-3a,5,8,9,12,14,17,17-octamethyl-7,12,16,20a-tetrapropyl-10,13-imino-4,20:9,16:18,15-trinitrilo-6H-cyclononadeca[b]furanato-N21,N22,N23,N24)-, stereoisomer
1,6-Dioxaspiro[4.5]decane-7-hexanoic acid, 2-[5-ethyltetrahydro-5-[tetrahydro-3-methyl-5-[tetrahydro-6-(hydroxym ethyl)-3,5-dimethyl-2H-pyran-2-yl]-2-furyl]-2-furyl]-9-hydroxy-.delta.-methoxy-.epsilon.,2,8-trimethyl-, methyl ester, diacetate
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
Water-dilutable, short-oil alkyd based on dehydrated castor oil (34% triglycerides, 25% phthalic anhydride); 55% solution in an aqueous glycol ether-alcohol mixture, neutralized with dimethylethanolamine
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
4H,6H,15H,17H-Tetrapyrano[2,3-f:2',3'-f':2'',3''-h:2''',3'''-h']cyclo buta[1,2-c:4,3-c']bis[1]benzopyran-4,17-dione, 10,10a,10b,11,20c,20d-hexahydro-2,6,6,10,10,11,11,15,15,19-decamethyl-, [10aS-(10a.alpha.,10b.beta.,20c.beta.,20d.alpha.)]-
| Title | Journal or Book | Year |
|---|---|---|
| Oxazaphospholidine-oxide as an Efficient ortho-Directing Group for the Diastereoselective Deprotonation of Ferrocene | Organic Letters | 2005 |